Discovery and preclinical validation of drug indications using compendia of public gene expression data.
Discovery and preclinical validation of drug indications using compendia of public gene expression data.
复制标题
DOI:
10.1126/scitranslmed.3001318
复制
发表时间:
2011-08-17
影响因子:
17.1
通讯作者:
Butte AJ
中科院分区:
文献类型:
--
作者:
Sirota M;Dudley JT;Kim J;Chiang AP;Morgan AA;Sweet-Cordero A;Sage J;Butte AJ
The application of established drug compounds to novel therapeutic indications, known as drug repositioning, offers several advantages over traditional drug development, including reduced development costs and shorter paths to approval. Recent approaches to drug repositioning employ high-throughput experimental approaches to assess a compound’s potential therapeutic qualities. Here we present a systematic computational approach to predict novel therapeutic indications based on comprehensive testing of molecular signatures in drug-disease pairs. We integrated gene expression measurements from 100 diseases and gene expression measurements on 164 drug compounds yielding predicted therapeutic potentials for these drugs. We demonstrate the ability to recover many known drug and disease relationships using computationally derived therapeutic potentials, and also predict many new indications for these drugs. We experimentally validated a prediction for the anti-ulcer drug cimetidine as a candidate therapeutic in the treatment of lung adenocarcinoma, and demonstrate both in vitro and in vivo using mouse xenograft models. This novel computational method provides a novel and systematic approach to reposition established drugs to treat a wide range of human diseases.
登录
查看更多内容
影响因子:
11.5
作者:
Abbas, Sabiha;Bhoumik, Anindita;Ronai, Zeev A.
通讯作者:
Ronai, Zeev A.
影响因子:
46.9
作者:
Butte, AJ;Kohane, IS
通讯作者:
Kohane, IS
影响因子:
56.9
作者:
Campillos, Monica;Kuhn, Michael;Bork, Peer
通讯作者:
Bork, Peer
影响因子:
8.4
作者:
Fichtner, I;Slisow, W;Bibby, M
通讯作者:
Bibby, M
影响因子:
45.3
作者:
Del Rio, Maguy;Molina, Franck;Ychou, Marc
通讯作者:
Ychou, Marc